SE421426B - Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion - Google Patents
Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dionInfo
- Publication number
- SE421426B SE421426B SE7605927A SE7605927A SE421426B SE 421426 B SE421426 B SE 421426B SE 7605927 A SE7605927 A SE 7605927A SE 7605927 A SE7605927 A SE 7605927A SE 421426 B SE421426 B SE 421426B
- Authority
- SE
- Sweden
- Prior art keywords
- isopropylendioxy
- 16alfa
- 17alfa
- crystallinic
- 11beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58130175A | 1975-05-27 | 1975-05-27 | |
US58130075A | 1975-05-27 | 1975-05-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7605927L SE7605927L (sv) | 1976-11-28 |
SE421426B true SE421426B (sv) | 1981-12-21 |
Family
ID=27078279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7605927A SE421426B (sv) | 1975-05-27 | 1976-05-25 | Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS51144719A (sv) |
AT (1) | AT357702B (sv) |
AU (1) | AU506080B2 (sv) |
CA (1) | CA1075228A (sv) |
DE (2) | DE2661037C2 (sv) |
ES (1) | ES448220A1 (sv) |
FR (1) | FR2361900A1 (sv) |
GB (1) | GB1525181A (sv) |
HK (1) | HK8580A (sv) |
IL (1) | IL49652A (sv) |
MX (1) | MX3864E (sv) |
MY (1) | MY8000275A (sv) |
NL (1) | NL191234C (sv) |
NZ (1) | NZ180946A (sv) |
SE (1) | SE421426B (sv) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1133092B (it) * | 1979-05-21 | 1986-07-09 | Syntex Corp | Procedimento per la preparazione del flunisolide |
EP0039369B1 (en) * | 1980-05-02 | 1983-06-15 | Schering Corporation | Beclomethasone ester solvates, process for their preparation, and preparation of a formulation |
GB2127689B (en) * | 1982-10-05 | 1986-07-09 | Sandoz Ltd | Calcitonin inhalation compositions |
US4782047A (en) * | 1986-05-22 | 1988-11-01 | Syntex Pharmaceuticals International Ltd. | Aqueous steroid formulations for nasal administration |
JP2843857B2 (ja) * | 1988-10-05 | 1999-01-06 | ファルマシア・アンド・アップジョン・カンパニー | 反溶剤への沈澱を介する微細分化固体結晶性粉末 |
US5707634A (en) * | 1988-10-05 | 1998-01-13 | Pharmacia & Upjohn Company | Finely divided solid crystalline powders via precipitation into an anti-solvent |
DE4003272A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
CA2225601C (en) * | 1995-06-27 | 2003-10-14 | Boehringer Ingelheim Kg | New stable pharmaceutical preparation for producing propellant-free aerosols |
DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
JP5392880B2 (ja) | 2000-05-22 | 2014-01-22 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 加圧式定量吸入器のための安定な製薬学的溶液製剤 |
TR200401980T4 (tr) | 2001-07-02 | 2004-09-21 | Chiesi Farmaceutici S.P.A. | Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu |
JP4632687B2 (ja) * | 2003-04-25 | 2011-02-16 | ロート製薬株式会社 | 点鼻剤 |
JP5238779B2 (ja) * | 2003-04-25 | 2013-07-17 | ロート製薬株式会社 | 点鼻剤 |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
CA2905587A1 (en) | 2013-03-15 | 2014-09-18 | Medicis Pharmaceutical Corporation | Topical compositions of flunisolide and methods of treatment |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3126375A (en) * | 1964-03-24 | Chioacyl | ||
BE585432A (fr) * | 1958-12-08 | 1960-06-08 | American Cyanamid Co | Stéroïdes fluorés. |
US3282791A (en) * | 1965-08-17 | 1966-11-01 | Merck & Co Inc | Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate |
US3592930A (en) * | 1968-07-19 | 1971-07-13 | Syntex Corp | Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle |
FR2038105A1 (fr) * | 1969-04-01 | 1971-01-08 | Syntex Corp | Composition anti-inflammatoire locale et son mode d'utilisation |
GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
DE2332663C2 (de) * | 1973-06-23 | 1986-07-31 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie |
US3934013A (en) * | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
-
1976
- 1976-05-14 MX MX76234U patent/MX3864E/es unknown
- 1976-05-25 SE SE7605927A patent/SE421426B/sv not_active IP Right Cessation
- 1976-05-25 IL IL49652A patent/IL49652A/xx unknown
- 1976-05-25 NZ NZ180946A patent/NZ180946A/xx unknown
- 1976-05-25 CA CA253,267A patent/CA1075228A/en not_active Expired
- 1976-05-25 ES ES448220A patent/ES448220A1/es not_active Expired
- 1976-05-26 JP JP51061032A patent/JPS51144719A/ja active Granted
- 1976-05-26 NL NL7605699A patent/NL191234C/xx not_active IP Right Cessation
- 1976-05-26 AU AU14301/76A patent/AU506080B2/en not_active Expired
- 1976-05-26 FR FR7616040A patent/FR2361900A1/fr active Granted
- 1976-05-26 GB GB21936/76A patent/GB1525181A/en not_active Expired
- 1976-05-26 AT AT388376A patent/AT357702B/de not_active IP Right Cessation
- 1976-06-03 DE DE2661037A patent/DE2661037C2/de not_active Expired
- 1976-06-03 DE DE2624924A patent/DE2624924C2/de not_active Expired
-
1980
- 1980-03-06 HK HK85/80A patent/HK8580A/xx unknown
- 1980-12-30 MY MY275/80A patent/MY8000275A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2361900B1 (sv) | 1979-04-13 |
MX3864E (es) | 1981-08-26 |
JPS51144719A (en) | 1976-12-13 |
IL49652A0 (en) | 1976-07-30 |
JPS6247880B2 (sv) | 1987-10-09 |
NL191234B (nl) | 1994-11-01 |
ES448220A1 (es) | 1977-11-01 |
IL49652A (en) | 1979-05-31 |
NL7605699A (nl) | 1976-11-30 |
NL191234C (nl) | 1995-04-03 |
DE2624924A1 (de) | 1977-12-15 |
SE7605927L (sv) | 1976-11-28 |
CA1075228A (en) | 1980-04-08 |
GB1525181A (en) | 1978-09-20 |
DE2661037C2 (sv) | 1989-04-06 |
FR2361900A1 (fr) | 1978-03-17 |
AT357702B (de) | 1980-07-25 |
AU506080B2 (en) | 1979-12-13 |
DE2624924C2 (de) | 1986-11-27 |
ATA388376A (de) | 1979-12-15 |
NZ180946A (en) | 1978-07-28 |
AU1430176A (en) | 1977-12-01 |
MY8000275A (en) | 1980-12-31 |
HK8580A (en) | 1980-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE421426B (sv) | Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion | |
SE420599B (sv) | Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon | |
SE7607771L (sv) | Sett for framstellning av utvidgningsbara perlor | |
SE445039B (sv) | Sett att framstella cement av portlandtyp | |
SE7602706L (sv) | Forfarande for framstellning av oorganisk - organiska plaster | |
SE422077B (sv) | Sett att framstella syntesgas | |
SE427748B (sv) | Forfarande for framstellning av frostherdig betong | |
DK554179A (da) | Fremgangsmaade til fremstilling af ergolinderivater | |
SE7611629L (sv) | Sett att framstella expanderad slagg | |
SE437155B (sv) | Sett att framstella nya derivat av perhydro-aza-heterocykler | |
SE7608927L (sv) | Sett att framstella pyridinderivat | |
NO142520C (no) | Fremgangsmaate til fremstilling av fleksible sprengstoff-formlegemer | |
SE413771B (sv) | Sett att framstella nya derivat av 5h-dibebs(b,f)azepin | |
SE7603359L (sv) | Sett for direkt framstellning av rastal | |
SE7903977L (sv) | Forfarande for framstellning av konstruktionselement bestaende av gipsskum | |
SE7607239L (sv) | Sett att framstella beta-acylpyrroler | |
NO144886C (no) | Fremgangsmaate til fremstilling av oksiranforbindelser | |
SE7612886L (sv) | Sett vid framstellning av koncentrerade suspensioner | |
SE420690B (sv) | Sett att kontinuerligt framstella vermeisolerande ledningsror | |
SE420982B (sv) | Sett att styra en omformningsprocess jemte anordning for genomforande av settet | |
SE420731B (sv) | Sett att framstella 5-androsten-17-on-derivat | |
SE412233B (sv) | Sett att framstella nya fenotiazinderivat | |
SE427196B (sv) | Sett vid tillverkning av cellulosamassa | |
SE432926B (sv) | Sett att framstella disubstituerade fenoletrar av 3-amino-2-hydroxipropan | |
SE7508654L (sv) | Forfarande for framstellning av steroider |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7605927-8 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7605927-8 Format of ref document f/p: F |